1. Home
  2. ARWR vs NYAX Comparison

ARWR vs NYAX Comparison

Compare ARWR & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • NYAX
  • Stock Information
  • Founded
  • ARWR 2003
  • NYAX 2005
  • Country
  • ARWR United States
  • NYAX Israel
  • Employees
  • ARWR N/A
  • NYAX N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • NYAX
  • Sector
  • ARWR Health Care
  • NYAX
  • Exchange
  • ARWR Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • ARWR 1.8B
  • NYAX 1.7B
  • IPO Year
  • ARWR 1993
  • NYAX N/A
  • Fundamental
  • Price
  • ARWR $18.31
  • NYAX $43.59
  • Analyst Decision
  • ARWR Buy
  • NYAX Buy
  • Analyst Count
  • ARWR 8
  • NYAX 6
  • Target Price
  • ARWR $43.71
  • NYAX $41.67
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • NYAX 21.1K
  • Earning Date
  • ARWR 08-07-2025
  • NYAX 08-06-2025
  • Dividend Yield
  • ARWR N/A
  • NYAX N/A
  • EPS Growth
  • ARWR N/A
  • NYAX N/A
  • EPS
  • ARWR N/A
  • NYAX 0.18
  • Revenue
  • ARWR $545,209,000.00
  • NYAX $331,161,000.00
  • Revenue This Year
  • ARWR $21,924.50
  • NYAX $33.44
  • Revenue Next Year
  • ARWR N/A
  • NYAX $23.74
  • P/E Ratio
  • ARWR N/A
  • NYAX $245.78
  • Revenue Growth
  • ARWR 1436.97
  • NYAX 34.05
  • 52 Week Low
  • ARWR $9.57
  • NYAX $20.31
  • 52 Week High
  • ARWR $30.41
  • NYAX $52.46
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 66.51
  • NYAX 41.33
  • Support Level
  • ARWR $16.45
  • NYAX $42.88
  • Resistance Level
  • ARWR $19.24
  • NYAX $52.46
  • Average True Range (ATR)
  • ARWR 0.79
  • NYAX 1.30
  • MACD
  • ARWR 0.25
  • NYAX -0.89
  • Stochastic Oscillator
  • ARWR 77.43
  • NYAX 7.46

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: